Skip to content

The preemptive effect of a single dose Harpagophytum (Teltonal480mg capsule) for controlling of post operative pain after unilateral inguinal hernia

The preemptive effect of a single dose Harpagophytum (Teltonal480mg capsule) for controlling post operative pain after unilateral inguinal hernia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201308181772N11
Enrollment
60
Registered
2013-09-14
Start date
2012-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia. ????? ??? ??? ?? ??? ??? ????????? ??????

Interventions

Intervention 1: Using Teltonal 480mg capsule, One hour before anesthesia in the study group. Intervention 2: Without taking Teltonal capsules, One hour before Anesthesia in the control group.
Treatment - Drugs
Using Teltonal 480mg capsule, One hour before anesthesia in the study group
Without taking Teltonal capsules, One hour before Anesthesia in the control group

Sponsors

Tabriz University of Medical Science - Research team of anesthesiology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: were age between 20-60 years; candidate for inguinal hernia surgery exclusion criteria: were drug addiction; lactation period; history of pain killer drugs; drug sensitivity; heart disease; peptic ulcer history ; patient‘s lack of consent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 0,2, 6, 12, 24 o'clock postoperative. Method of measurement: visual analogue scale.

Secondary

MeasureTime frame
Analgesic drugs. Timepoint: 0,2, 6, 12, 24 o'clock postoperative. Method of measurement: Milligram/ Dose.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDawood Aghamohammadi

Anesthesiology Dept

aghamohammmadid@tbzmed.ac.ir+98 41 1381 8940

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026